Stocks · Health care · Biological Products, (No Diagnostic Substances)

DBV Technologies S.A.

DBVT Clue Score35

France Fiscal year ends December CIK 0001613780 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Net buying

Individual transactions

Insider

Date

Role

Action

Price

Amount

Daniel Tasse

8 Mar 2024

Chief Executive Officer

Buy

17,094

$0.83

$14.19K

Adora Ndu

6 Feb 2024

Director

Buy

1,825

$0.89

$1.62K

Timothy E Morris

25 Aug 2023

Director

Buy

12,000

$1.52

$18.24K

Daniel B Soland

1 Aug 2023

Director

Buy

15,000

$1.62

$24.30K

Show all 23 transactions →

What was left out

Form 4 filings counted 39

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 19

Transactions with no price 3

Shares from compensation/vesting 12,163,200

History held since 11 Jun 2021